Aberrant RL2 O-GlcNAc antibody reactivity against serum-IgA1 of patients with colorectal cancer. Verathamjamras C, Sriwitool TE, Netsirisawan P, Chaiyawat P, Chokchaichamnankit D, Prasongsook N, Srisomsap C, Svasti J, Champattanachai V*. Glycoconj J. 2021 Feb;38(1):55-65.

01 Feb 2021
0

Aberrant RL2 O-GlcNAc antibody reactivity against serum-IgA1 of patients with colorectal cancer.

Verathamjamras C, Sriwitool TE, Netsirisawan P, Chaiyawat P, Chokchaichamnankit D, Prasongsook N, Srisomsap C, Svasti J, Champattanachai V*.

Glycoconj J. 2021 Feb;38(1):55-65.

Tags

Share this

Related Posts

Microbial source tracking using molecular and cultivable methods in a tropical mixed-use drinking water source to support water safety plans

Recent Posts